Translational control plays a key role in many biological processes including pattern formation during early Drosophila embryogenesis. In this process, the anterior determinant Bicoid (BCD) acts not only as a transcriptional activator of segmentation genes but also causes specific translational repression of ubiquitously distributed caudal (cad) mRNA in the anterior region of the embryo. We show that translational repression of cad mRNA is dependent on a functional eIF4E-binding motif. The results suggest a novel mode of translational repression, which combines the strategy of target-specific binding to 3-untranslated sequences and interference with 5-cap-dependent translation initiation in one protein.
Pattern formation during early Drosophila embryogenesis is initiated by an asymmetric distribution of the maternal transcription factors Bicoid (BCD), Hunchback (HB), and Caudal (CAD) in a single cell, the egg (for review, see St Johnston and Nü sslein-Volhard 1992; Rivera-Pomar and Jä ckle 1996). HB and CAD form concentration gradients along the longitudinal axis that are generated by the spatially restricted translational repression of evenly distributed maternal mRNA (Curtis et al. 1995 ; for review, see Wickens et al. 2000) . In contrast, the concentration gradient of the anterior determinant BCD derives from prelocalized maternal mRNA in the anterior pole region of the embryo (for review, see St Johnston and Nü sslein-Volhard 1992; Hake and Richter 1997) . BCD acts as a transcriptional activator of segmentation genes (for review, see Driever 1993) and causes specific translational repression of caudal (cad) mRNA in the anterior region of the embryo (Tautz 1988; Struhl et al. 1989; Dubnau and Struhl 1996; . Translational repression of cad mRNA involves the binding of BCD to a distinct cis-acting element within the 3Ј-untranslated region (UTR) of the mRNA (Dubnau and Struhl 1996; and functions in a 5Ј-cap-dependent manner in cell culture (Niessing et al. 1999) .
The cap-dependent mode of translation depends on the assembly of an evolutionarily conserved protein complex that is initiated by the binding of the translation initiation factor 4E (eIF4E) to the m 7 GpppN-cap structure (Shatkin 1976 ; for review, see Merrick and Hershey 2000; Raught et al. 2000) . Subsequently, the adapter protein eIF4G binds to eIF4E and allows additional factors (including eIF4A, eIF4B, eIF1, eIF1A, eIF2, eIF3, and the ribosomal subunits) to assemble into a complex that initiates translation (for review, see Merrick and Hershey 2000; Raught et al. 2000) . The cap-dependent translation initiation process can be regulated by eIF4E-binding proteins such as BP1, BP2, and Maskin (for review, see Raught et al. 2000; Sachs and Varani 2000) . They block the eIF4E ϻ eIF4G association through outcompeting binding to eIF4E, involving a small eIF4E-binding motif of the minimal consensus sequence YxxxxL (for review, see Raught et al. 2000; Richter 2000; Sachs and Varani 2000) . Here we show that BCD contains a functional eIF4E-binding motif and that the translational repression of cad mRNA is dependent on this motif in vivo. The results suggest that 3Ј-UTR-bound BCD interferes with the assembly of the initiation complex and thereby causes repression of cad mRNA translation.
Results

BCD associates with a 5Ј-cap-bound protein in vitro
The cap-dependence of cad mRNA translational inhibition suggested that 3Ј-UTR-bound BCD interacts with one or several components of the translation initiation complex at the 5Ј-end (Niessing et al. 1999) . To test whether BCD can associate with these cap-bound pro-teins, we produced cytoplasmic extracts of early Drosophila embryos and asked whether BCD can associate with m 7 GTP-sepharose, serving as a cap analog (Edery et al. 1988; Pyronnet et al. 2001) . The m 7 GTP-sepharosebound protein fraction of wild-type extracts contained a series of proteins including eIF4E (Edery et al. 1988; Pyronnet et al. 2001 ; data now shown) and a single protein that was absent from cytoplasmic extracts of embryos derived from homozygous bcd mutant females (Fig. 1a, lanes 1,3) . Anti-BCD antibody staining of Western blots (Fig. 1a, lanes 2,4) showed that this protein is BCD. We also examined protein extracts from embryos that expressed a transgene-derived, cDNA-based GFP-BCD fusion protein (Hazelrigg et al. 1998) . The GFP-BCD fusion protein was recovered from the m 7 GTP-sepharose-bound protein fraction as shown by SDS-PAGE analysis (Fig. 1b, lanes 1,2) and Western blots stained with anti-BCD (Fig. 1b, lanes 3,4) and anti-GFP (Fig. 1b, lanes 5,6) antibodies, respectively.
BCD contains a functional eIF4E-binding motif
In searching for the cap-bound protein with which BCD associates, we noted a potential eIF4E-binding motif Figure 1 . BCD copurifies with 5Ј-cap-bound proteins. Cytoplasmic protein extracts of young embryos were affinity-purified using a cap-analog m 7 GTP-sepharose resin (Edery et al. 1988) . (a) Silver-stained SDS-PAGE of affinity-purified proteins contained within cytoplasmic extracts of wild-type and bcd mutant Drosophila embryos. Arrowhead marks the protein band that was subsequently identified as BCD (left, see also lanes 1-4 in b). Note that eIF4E, the most abundant 30-kD component among the purified proteins, is run off the gel (left) to obtain maximum resolution of the relevant range of protein bands between 50 and 100 kD. (Lanes 1-4 Berleth et al. 1988) showing the homeodomain (HD, gray box; position 91-154), the PEST domain (PEST, black box; position 170-203), and a YIRPYL motif (green box; position 68-73). The eIF4E-binding properties of this motif have been recently analyzed in great detail in the context of human BP1 (Marcotrigiano et al. 1999 ; for review, see Raught et al. 2000; Sachs and Varani 2000; Miron et al. 2001) . ( (YIRPYL) N-terminal to the BCD homeodomain (Fig. 1c) . To test whether cap association of BCD could be mediated by eIF4E, we precoupled recombinant eIF4E to m 7 GTP-sepharose, incubated it with protein extracts from preblastoderm stage Drosophila embryos, and examined the eIF4E-associated proteins. SDS-PAGE followed by Western blot analysis identified BCD among the retained proteins (Fig. 1d, lanes 1,4) . We next asked whether BCD binding could be competed for by adding increasing amounts of the YxxxxL-containing peptide of human BP1, which had been shown to compete efficiently for binding at the eIF4G-binding site of eIF4E (Marcotrigiano et al. 1999; Ptushkina et al. 1999 ; for review, see Raught et al. 2000; Richter 2000; Sachs and Varani 2000) . Figure 1d indicates that the YxxxxL-containing peptide (Fig. 1d , lanes 2,3,5) competes for the binding of BCD to m 7 GTP-sepharose-associated proteins, whereas the corresponding peptide in which the conserved Y and L residues of the eIF4E-binding motif were replaced by A and R (Fig. 1d , cf. lanes 4-6) does not. This finding is consistent with earlier results showing that mutations in corresponding positions of the motif were able to abolish eIF4E binding (Miron et al. 2001) . The data therefore suggest that BCD interacts with the eIF4E-containing 5Ј-cap complex via the eIF4E-binding site in a manner similar to BP1.
To show that BCD and eIF4E can interact directly, we coupled recombinant eIF4E to m 7 GTP-sepharose and examined its association with in vitro translated 35 Slabeled full-length BCD (Fig. 1e) and BCD 1-489AR mutant protein (Fig. 1f) . We observed specific binding of in vitro translated BCD to recombinant eIF4E (Fig. 1e) . This interaction was absent in the case of BCD 1-489AR mutant protein (Fig. 1, cf. e and f) and depended on the presence of cad 3Ј-UTR mRNA in the reaction mixture (Fig. 1e) , implying that the association of BCD with target mRNA is a prerequisite for the binding. Collectively, these results suggest that BCD binds eIF4E directly and that the binding requires the intact YxxxxL motif. We would like to emphasize that the in vitro interaction of BCD and eIF4E may require cofactors present in the reticulocyte lysate used for the in vitro translation of BCD.
Translational repression of cad mRNA depends on the eIF4E-binding motif of BCD
We next asked whether the eIF4E-binding motif of BCD is necessary for mediating translational repression of cad mRNA in the embryo. We generated BCD deletion mutants ( Fig. 2a) and examined their transgene-derived activities in embryos from homozygous bcd mutant females (Frohnhö fer and Nü sslein-Volhard 1986). Embryos without BCD activity fail to repress translation of cad mRNA in the anterior region (Fig. 2, cf. b and e), lack anterior hb activation (Fig. 2 , cf. c and f) and head and thorax development (Fig. 2, Berleth et al. 1988; ; for review, see Driever 1993) . Transgene-derived expression of full-size BCD 1-489 (Fig. 2a) rescued all aspects of BCD requirement during Drosophila embryogenesis (Frohnhö fer and Nü sslein-Volhard 1986; Berleth et al. 1988; ; for review, see Driever 1993) including repression of cad mRNA translation (Fig. 2h-j) . Transgene-dependent expression of the deletion mutant BCD , containing the N-terminal half of BCD that includes the eIF4E-binding motif, the RNAbinding homeodomain, and the PEST domain (Fig. 2a) , restores translational repression of cad mRNA in the anterior pole region of the embryo (Niessing et al. 1999) . In contrast, BCD deletion mutants lacking the eIF4E- Dubnau and Struhl 1996; , by activation of zygotic hb transcription as revealed by whole mount in situ hybridization with an hb cDNA probe (c; Klingler and Gergen 1993; reviewed in Martinez Arias 1993) , and by the wild-type cuticle pattern (d). (e-g) Embryos derived from homozygous bcd E1 mutant females fail to repress cad mRNA translation (e), lack the anterior hb expression domain (which is replaced by a duplication of the posterior, BCD-independent hb expression domain; f), and show a bcd mutant cuticle phenotype (g; Frohnhö fer and Nü sslein-Volhard 1986). (h-j) Transgene-derived BCD 1-489 expression restores all aspects of the bcd mutant phenotype including translational repression of cad mRNA (h), anterior hb expression (i), and the larval cuticle phenotype (j). (k-m) cad mRNA translation is not repressed in response to transgene-derived BCD 77-202 (k) or BCD 89-202 (data not shown). In both cases, the transgene-expressed BCD deletion mutants also fail to restore anterior hb expression (l) and develop a bcd mutant cuticle phenotype (m) because of the absence of the C-terminal transactivation domains (Sauer et al. 1995; Schaeffer et al. 1999) . Orientation of embryos is anterior left and dorsal up.
binding motif, such as BCD or BCD (Fig. 2a) , did not repress translation (Fig. 2k) . Furthermore, earlier studies had shown that a deletion mutant that lacks the N-terminal 29 amino acids is able to repress cad mRNA translation (Dubnau and Struhl 1996) . The 47-aminoacid sequence interval between amino residues 29 and 77 of BCD, which includes the eIF4E-binding motif in position 68-73 (Fig. 2a) , is therefore necessary for the BCD-dependent translational control in vivo.
To show that the eIF4E-binding motif of BCD itself is needed to exert translational repression on cad mRNA, we performed transgene-dependent rescue experiments with bcd mutant embryos. We expressed mutant BCD proteins in which Y and L of the eIF4E-binding motif had been replaced by A and R residues. Transgene-dependent expression of mutant BCD 1-202AR protein (Fig. 3a) did not repress translation of cad mRNA in the anterior region of the embryo (Fig. 3b) and was unable to activate hb transcription (Fig. 3d) or rescue the segmentation defects of the mutants (Fig. 3f) . Expression of BCD 1-489AR , which in contrast to BCD 1-202AR contains the C-terminal transcriptional activation domains (Sauer et al. 1995; Schaeffer et al. 1999) , also failed to restore the translational repression of cad mRNA (Fig. 3c) . However, it supported transcriptional activation of BCD-dependent hb expression (Fig. 3e ) and head and thorax development (Fig. 3g) . These results indicate that the eIF4E-binding motif of BCD is not essential for transcriptional activity of BCD but is specifically required for translational repression of cad mRNA.
Discussion
The results show that BCD can associate with cap-associated eIF4E in vitro and that the eIF4E-binding motif of BCD is necessary for BCD-dependent translational repression of cad mRNA in the embryo. These findings suggest a repression mechanism in which BCD blocks the eIF4G ϻ eIF4E interaction necessary for the initiation of cap-dependent cad mRNA translation. Because no interaction between recombinant eIF4E and BCD could be detected in the absence of cad mRNA, we conclude that the binding of BCD to the cad 3Ј-UTR is most likely a prerequisite for their interaction. This interpretation is consistent with previous findings where a mutant BCD, which specifically lacks its ability to bind cad mRNA, was also unable to repress translation (Niessing et al. 2000) .
BCD-dependent control of translation of cad mRNA is likely to function in a manner similar to BP1, BP2, and Maskin (for review, see Raught et al. 2000; Richter 2000) . However, despite the intriguing similarities among BP1/BP2, Maskin, and BCD, the modes of how they exert translational repression are distinct (Fig. 4) . BP1 and BP2 are part of a general mRNA repression system, which blocks eIF4E ϻ eIF4G interaction in a reversible, cellgrowth-dependent manner in response to insulin receptor signaling ( Fig. 4a ; for review, see Raught et al. 2000; Sachs and Varani 2000) . In contrast, Maskin represses translation in an mRNA-specific manner. It binds to the cytoplasmic polyadenylation element-binding protein (CPEB), a factor that interacts with a short uridine-rich cytoplasmic polyadenylation element (CPE) of cyclin B mRNA. CPEB-tethered Maskin acts from the 3Ј-end of specific mRNAs by binding to eIF4E and blocking an association of eIF4E and eIF4G ( Fig. 4b; for review, see Richter 2000; Richter and Theurkauf 2001) . In this mode of repression, target specificity of repression is provided by the interaction of CPEB with the CPE, whereas the repression of translation at the 5Ј-end is executed by Maskin. BCD uses a strategy that combines these two features of CPEB and Maskin. Its homeodomain directly binds to the BCD response element (BRE) in the 3Ј-UTR of cad mRNA (Dubnau and Struhl 1996; ) and provides also a direct link to the 5Ј-capbound complex involving the eIF4E-interaction motif.
The simplest model to account for BCD-dependent repression of translation therefore involves three essential steps, which are (1) target recognition by binding to the specific target site within the 3Ј-UTR, a process mediated by BCD's arginine-rich RNA-binding motif in the homeodomain (Niessing et al. 2000) , (2) looping of cad mRNA to allow for interaction of the 3Ј-UTR-bound BCD with 5Ј-cap-bound eIF4E, which (3) causes a BP1/BP2-like blocking of the eIF4G-binding site on eIF4E (Fig. 4c) to prevent the assembly of a functional translation initiation complex. The mode of BCD-dependent repression of translation, therefore, combines the strategy of target-specific binding to 3Ј-UTRs as shown for a number of other translational repressors (Curtis et al. 1995; Hake and Richter 1997 ; for review, see Wickens et al. 2000) with a repression mechanism known from growth regulation (for review, see Raught et al. 2000; Sachs and Varani 2000) and cyclin B-dependent cell cycle regulation (for review, see Richter 2000; Richter and Theurkauf 2001) .
Materials and methods
Binding assays
About 300 µL of embryos (0-3 h) was homogenized with three strokes in 1.5 mL of buffer A (0.1 M KCl, 20 mM HEPES at pH 7.5, 0.2 mM EDTA, protease inhibitor cocktail; Boehringer Mannheim; 2-ml douncer, 4°C; Edery et al. 1988) . The homogenate was centrifuged (microcentrifuge, full speed; 4°C), and the supernatant was transferred into a new vial. Centrifugation was repeated twice, and the aqueous phase was then transferred into a 15-mL falcon tube containing 5 mL of buffer A and 0.5 mL of m 7 GTP-sepharose (Pharmacia). After incubation (1 h with slight agitation at 4°C), resins were washed 6× with 5 mL of buffer A + 100 µM GDP and centrifugation steps in between following a standard protocol (Edery et al. 1988) . Proteins bound to m 7 GTP-sepharose were eluted (two incubations in 1 mL of buffer A containing 100 µM m 7 GTP; 5 min each), and samples were concentrated and subsequently separated by SDS-PAGE (10% gel), followed by silver-staining or Western-blotting (monoclonal anti-BCD antibody, dilution 1:50, and secondary goat anti-mouse antibodies, dilution 1:2000 or rabbit anti-GFP, Santa Cruz, dilution 1:500, and secondary goat anti-rabbit antibodies, dilution 1:2000). Secondary antibodies were peroxidasecoupled. Protein was visualized with SuperSignal Chemiluminescent Substrate (Pierce).
For the peptide competition assay, 600 µL of m 7 GTP-beads was incubated with 750 µL of recombinant Drosophila eIF4E-⌬N-term (Marcotrigiano et al. 1999 ; 0.29 µg/µL) at 4°C for 2 h. Subsequently, the resin with bound 4E was washed 3× with 5 mL of buffer and incubated with 4 mL of lysate derived from 0-3-h embryos in buffer A. After incubation at 4°C for 2 h with slight agitation, the resin was washed 3× with buffer A and afterward split into three parts, which were incubated 3× at 4°C for 10 min under slight agitation either with buffer A containing 100 µM GDP, or with buffer A containing 100 µM GDP and 1 mM human BP1 peptide (STTPGGTRIIYDRKFLMECRNSPV-TKT) or the mutant version (STTPGGTRIIADRKFRMECRNS-PVTKT) of it. Proteins bound to the resin were subsequently eluted (two incubations in 200 µL of buffer A containing 500 µM m 7 GTP; 5 min under slight agitation), concentrated, and separated by SDS-PAGE (12% gel), followed by Western-blotting (monoclonal anti-BCD, dilution 1:50, and secondary biotinylated rat anti-mouse antibodies, dilution 1:1000). Proteins were visualized using the AP-conjugated Vectastain ABC-kit (Vector Laboratories).
In vitro binding assays were carried out with 100 µL of m 7 GTP-beads. They were precoupled with 50 µL of recombinant Drosophila eIF4E-⌬N-term (0.29 µg/µL) and blocked with 5 µL of purified BSA (100 µg/µL) at 4°C for 2 h. Subsequently, the resin with bound eIF4E was washed 3 times with 1 mL of buffer A. Full-length BCD and BCD 1-489AR were in vitro translated and 35 S-labeled using the TNT T7 Quick Coupled Transcription/Translation System (PROMEGA) and the Pro Mix 35 S-methionine/cysteine in vitro cell-labeling-mix (Amersham Biosciences) according to the manufacturers' instructions. Of the 50 µL of in vitro translation mix, 10 µL was preincubated with ∼ 20 µg of in vitro transcribed cad 3Ј-UTR mRNA including the BCD response element (Dubnau and Struhl 1996; Rivera-Pomera et al. 1996) at 4°C for 1 h. This preincubation mix was incubated with the washed eIF4E-coupled m 7 GTP-beads, incubated at 4°C for 2 h, and afterward washed 5× for 10 min with buffer A. Subsequently, eIF4E and associated proteins were specifically eluted in 50 µL of buffer A containing 500 µM m 7 GTP (20 min on ice under slight agitation). Eluted proteins as well as 3 µL of the in vitro translation input were analyzed by SDS-PAGE followed by autoradiography.
DNA encoding BCD 1-489AR was generated by PCR-based mutagenesis involving a full-size BCD cDNA clone as described in Niessing et al. (1999) , and the sequence was verified by DNA sequencing. . Different modes of cap-dependent translational repression by interference with the assembly of the eIF4E ϻ eIF4G interaction complex. (a) Binding of BP to eIF4E blocks eIF4G-binding and modulates translation efficiency of 5Ј-capped mRNAs in an insulin signaling-dependent manner (for review, see Raught et al. 2000; Sachs and Varani 2000) . (b) Translational repression of mRNAs, which anchor CPEB through a CP element in their 3Ј-UTR. CPEB is able to associate with Maskin, which successively blocks the eIF4E ϻ eIF4G interaction by binding to eIF4E (for review, see Richter 2000; Richter and Theurkauf 2001) . (c) BCD uses a similar strategy of repression by combining the binding properties of both CPEB and Maskin. BCD binds directly to the BRE in the 3Ј-UTR and blocks the eIF4E ϻ eIF4G interaction at the 5Ј-end. In each case (a-c), the eIF4E interaction involves the YxxxxL motif of the translational repressors.
Transgenes and mutant analysis
In vitro mutagenized bcd cDNAs (QuikChange kit, Stratagene) were cloned into the P-element-based pCaSpeR vector DNA bearing the nanos 5Ј sequences and the bcd 3Ј-UTR (Niessing et al. 1999) . Several transgenic lines were established by P-element-mediated germ-line transformation as described (Niessing et al. 1999 (Niessing et al. , 2000 and crossed to bcd E1 mutants. Transgene-dependent zygotic hb expression and Cad gradient formation were monitored by whole mount in situ hybridization (Tautz and Pfeifle 1989; Klingler and Gergen 1993) and antibody staining (Niessing et al. 1999 (Niessing et al. , 2000 using guinea-pig anti-Cad antibodies (dilution 1:300) and goat anti-guinea-pig Cy3-labeled antibodies (dilution 1:500; after preabsorption). Larval cuticles were prepared and analyzed as described (Martinez Arias 1993) .
